Connor, Clark & Lunn Investment Management (CC&L)’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-72,973
| Closed | -$270K | – | 867 |
|
|
2017
Q4 | $270K | Sell |
72,973
-2,000
| -3% | -$7.4K | ﹤0.01% | 695 |
|
|
2017
Q3 | $307K | Buy |
74,973
+4,461
| +6% | +$18.3K | ﹤0.01% | 706 |
|
|
2017
Q2 | $262K | Buy |
70,512
+33,627
| +91% | +$125K | ﹤0.01% | 698 |
|
|
2017
Q1 | $153K | Buy |
+36,885
| New | +$153K | ﹤0.01% | 823 |
|
|
2016
Q4 | – | Sell |
-15,833
| Closed | -$156K | – | 1052 |
|
|
2016
Q3 | $156K | Hold |
15,833
| – | – | ﹤0.01% | 751 |
|
|
2016
Q2 | $89K | Hold |
15,833
| – | – | ﹤0.01% | 810 |
|
|
2016
Q1 | $121K | Hold |
15,833
| – | – | ﹤0.01% | 755 |
|
|
2015
Q4 | $211K | Hold |
15,833
| – | – | ﹤0.01% | 694 |
|
|
2015
Q3 | $260K | Buy |
15,833
+3,016
| +24% | +$49.5K | ﹤0.01% | 613 |
|
|
2015
Q2 | $288K | Buy |
12,817
+434
| +4% | +$9.75K | ﹤0.01% | 504 |
|
|
2015
Q1 | $121K | Buy |
12,383
+2,833
| +30% | +$27.7K | ﹤0.01% | 525 |
|
|
2014
Q4 | $109K | Buy |
9,550
+5,017
| +111% | +$57.3K | ﹤0.01% | 548 |
|
|
2014
Q3 | $52K | Buy |
+4,533
| New | +$52K | ﹤0.01% | 534 |
|